Moneycontrol PRO

Check your Credit Score for Free and Get Guaranteed 100 Cash Reward!

Check your Credit Score for Free and Get Guaranteed ₹ 100 Cash Reward!

HomeNewsIndia

Covid-19 Tracker Highlights: Delhi reports first case of COVID-19 sub-variant JN.1: Officials

States asked to ensure effective compliance with operational guidelines for the revised surveillance strategy for Covid-19 shared by Centre.

December 27, 2023 / 10:56 PM IST
With the two new addition of Covid cases, a total of five cases of the viral disease have been reported in Odisha so far.

With the two new addition of Covid cases, a total of five cases of the viral disease have been reported in Odisha so far.

Delhi reported first case of COVID-19 sub-variant JN.1, according to officials, reported news agency PTI.

Delhi reports the first case of JN.1, a Sub-Variant of Omicron. Out of the 3 samples sent for Genome Sequencing, one is JN.1 & two are Omicron, said Delhi’s Health Minister Saurabh Bhardwaj.

In response to the unexpected spike in coronavirus infections throughout the nation, the All India Institute of Medical Sciences (AIIMS) in Delhi has released guidelines for Covid-19 suspected or positive cases that would be reported to hospitals.

India recorded 529 fresh COVID-19 cases in a single day, while the country's active infection count stood at 4,093, the health ministry said on December 27. Three new fatalities, two from Karnataka and one from Gujarat, were reported in a span of 24 hours, according to the ministry's data updated at 8 am.

States have been urged to ensure effective compliance with operational guidelines for the revised surveillance strategy for Covid-19 shared by the Union ministry of health and family welfare. They have asked to monitor and report district-wise cases of Influenza-like Illness (ILI) and Severe Acute Respiratory Illness (SARI) in all health facilities regularly for early detection of rising trend of cases.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Cases Across States

As per the daily data of last 24 hours released on December 27 , a maximum of 36 cases of the new variant were reported from Gujarat, 34 were reported from Karnataka, 14 from Goa, 9 from Maharashtra, 6 from Kerala, and, four from Rajasthan. In addition to this, Tamil Nadu reported four Covid-19 new variant cases and Telangana reported two, reported ANI citing sources.In a sigh of relief, most of the cases reported don't represent any clustering in areas. Moreover, most of the JN.1 subvariant cases have mild symptoms.

A fifty-eight-year-old daily wager died due to Covid-19 virus in Puducherry on Wednesday. He was suffering from Covid pneumonia and was undergoing treatment in a government hospital.

Covid Tracker

Advisory By Health Ministry

Despite the increasing number of cases and the detection of the JN.1 sub-variant in the country, officials emphasise that there is no immediate cause for concern. Ninety-two per cent of those infected are choosing home-based treatment, suggesting a mild illness, according to official statements.

The Director of Public Health and Family Welfare,  suggested childress of age less than 10 years and senior citizens to avoid steppijng out of house amid rising cases of Covid disease.

"Children less than 10 years of age and elders above 60 years of age are advised to avoid going outdoors unless mandatory. There is a higher incidence of COVID disease in the age group of 20 to 50 years, hence people are requested to exercise due precaution while going for work/essential activities. Everybody should wear a mask when he/she goes out of the house. Face masks are the first line of defence against Covid-19. Not wearing a mask is punishable by a fine," said the Director of Public Health & Family Welfare.

Covid variant JN1_6

What  WHO Has to Say

The World Health Organization (WHO) on December 19 declared JN.1 a variant of interest due to its "rapidly increasing spread”. But it did not label JN.1 a variant of concern yet.  "Based on the available evidence, the additional global public health risk posed by JN.1 is currently evaluated as low," WHO said.

Moneycontrol News
Tags: #Covid-19
first published: Dec 27, 2023 06:38 pm

Check Free Credit Score on Moneycontrol: Easily track your loans, get insights, and enjoy a ₹100 cashback on your first check!